Markison Brian A
- SEC CIK
- 0001283061
No open-market purchases or sales filed in the past year.
Current role at each company
- LNTH Lantheus Holdings, Inc.CEOas of Mar 7, 2025
- RVLP RVL Pharmaceuticals plcChief Executive Officeras of Aug 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Markison Brian A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LNTH Lantheus Holdings, Inc.
CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 (view filing) | Mar 27 | 2 days | Markison Brian ADirector | SSale | −13.3K | $81.13 | −$1.08M | −40.8%19.3K after | |
| Sep 12, 2022 (view filing) | Sep 8 | 4 days | Markison Brian ADirector | SSale | −41.8K | $84.24 | −$3.52M | −56.2%32.6K after | 3 lots |
| Sep 8, 2022 (view filing) | Sep 6 | 2 days | Markison Brian ADirector | SSale | −1.69K | $78.50 | −$132.9K | −3.3%50.0K after |
RVLP RVL Pharmaceuticals plc
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Markison Brian AChief Executive Officer | PPurchase | +850.0K | $1.55 | +$1.32M | +40.0%2.98M after |